The Misuse of Drugs (Amendment No.2) Regulations (Northern Ireland) 2024
The Misuse of Drugs (Amendment No.2) Regulations (Northern Ireland) 2024
Independent editorial summary — not the official statute text. Read the official version on legislation.gov.uk.
Type: NI Statutory Rule
Year: 2024
Number: 222
Made: 2024-12-19
Coming into force: 2025-01-15
Last ingested: 2026-06-12 from legislation.gov.uk.
Explanatory note
Reproduced verbatim from the instrument as published on legislation.gov.uk (Crown Copyright, Open Government Licence v3.0). The note is prepared by the responsible government department and is not part of the instrument itself.
These Regulations amend the Misuse of Drugs Regulations (Northern Ireland) 2002 ( S.R. 2002 No. 1 ) (“ the 2002 Regulations ”).
Regulation 2(2) adds twenty-one substances (four acyl piperazine opioids, two chemically bridged acyl piperazine derivatives, and fifteen novel benzodiazepines and related compounds) to Schedule 1 to the 2002 Regulations.
Regulation 2(3) adds an additional common name and the full International Union of Pure and Applied Chemistry name to the entry for methoxyphenidine, which is already included in Schedule 1 to the 2002 Regulations.
Regulation 2(4) adds a range of 2-benzyl benzimidazole variants to Schedule 1 to the 2002 Regulations.
Regulation 2(5) adds xylazine to Part 1 of Schedule 4 to the 2002 Regulations.
The Schedule in which a controlled drug is placed affects the extent to which the drug can be lawfully imported, exported, produced, supplied or possessed and dictates the controls that the drug is subject to, such as the record-keeping, labelling and destruction requirements in relation to that drug.